Prof. Christopher Palmer speaks with WBUR On Point host Meghna Chakrabarti about Americans and credit card debt, and how an interest rate cap could affect households across the country. “Anytime you have a price control, it has unintended consequences,” says Palmer. “Sometimes they're subtle. In this case, they're not subtle to see. We have lots of countries, lots of places where we've studied the effect of a cap on interest rates, and we see all sorts of unintended consequences.”
Research Scientist Christian Catalini, founder of the MIT Cryptoeconomics Lab, speaks with CNBC reporter Trevor Laurence Jockims about state and national initiatives to implement cryptocurrencies on a public balance sheet. “Once you’ve made that bet on infrastructure and industry, adding some Bitcoin exposure at the treasury level is a natural next step,” says Catalini.
Prof. Daron Acemoglu speaks with Bloomberg Businessweek Daily hosts Carol Massar and Tim Stenovec about American politics. “In my mind, worryingly, there is a little bit of a theory which is that all of these actions are aimed at centralizing power in the hands of an executive presidency with fewer and weaker checks which come either from institutions or norms.”
Prof. Barry Posen speaks with Newsweek reporter Andrew Stanton about the stockpile of United States weapons.
Prof. Jonathan Parker speaks with CNBC reporter Kate Dore about how larger tax refunds in 2026 could increase both consumer spending and inflation. “It could easily be inflationary,” says Parker.
Prof. John Sterman speaks with Guardian reporters Dharna Noor and Oliver Milman about the climate concerns surrounding increased oil production in Venezuela. “If there are millions of barrels a day of new oil, that will add quite a lot of carbon dioxide to the atmosphere and the people of Earth can’t afford that,” says Sterman.
Prof. Jonathan Gruber speaks with David Frum from The Atlantic’s “The David Frum Show” to shed light on the American healthcare system and health care disparities. “The issue in the U.S. is there are the haves and the have-nots—the haves get comparable health care to the rest of the world at a much higher price; the have-nots get worse health care at a much higher price,” says Gruber. “There’s really two fundamental challenges in U.S. health care: There’s disparities, and there’s costs.”
Prof. Jonathan Gruber speaks with Boston 25 reporter Amal Elhewl about the anticipated rise in healthcare premiums. Gruber predicts “prices could jump by as much as $25,000 a year for people like small business owners or entrepreneurs,” Elhewl explains. “If 4 to 5 million people lose health insurance, we’re talking about on the order of 5,000 extra deaths every year because we have not extended these subsidies,” adds Gruber.
Governor Maura Healey has announced a new initiative aimed at boosting the defense sector in Massachusetts, reports Katie Lannan for GBH. The Massachusetts governor noted that research institutions like MIT Lincoln Lab and Draper have been leaders in defense technology for years, and new startups in fields like AI, cybersecurity and quantum technology also aim to contribute to defense needs. “We want to work together, we want to continue these investments in bigger and stronger ways, looking to keep America secure for another 250 years,” says Healey.
Prof. Jonathan Gruber speaks with Newsweek reporter Jasmine Laws about catastrophic healthcare plans. "A common conservative criticism of public provision of health insurance is that we should just give folks 'skinny' or 'catastrophic' plans. But what these critics never grapple with is what would be included in these plans,” Gruber explains. “By the time you include anything that would be considered decent insurance – hospital, doctor, drugs, maternity care, mental health care – you are already at 90 percent of the cost of a generous insurance plan. The only way to really make a plan 'skinny' is to charge high deductibles, which many plans on the exchange already do."
Prof. Pierre Azoulay speaks with WBUR’s Martha Bebinger about a new study examining the potential impact of NIH budget cuts on the development of new medicines. Azoulay and his colleagues found that “more than half of drugs approved by the FDA since 2000 used NIH-funded research that would likely not have happened if the NIH had operated with a 40% smaller budget,” Bebinger explains.
Fierce Biotech reporter Darren Incorvaia writes that a new study by MIT researchers demonstrates how potential NIH budget cuts could endanger the development of new medications. The researchers found that if the NIH budget had been 40% smaller from 1980 to 2007, the level of NIH cuts currently being proposed, “the science underlying numerous drugs approved in the 21st century would not have been funded,” Incorvaia explains. The findings suggest that “massive cuts of the kind that are being contemplated right now could endanger the intellectual foundations of the drugs of tomorrow,” explains Professor Pierre Azoulay.
A new study co-authored by MIT researchers finds that more than half of the drugs approved by the FDA since 2000 are connected to NIH research that would be impacted by proposed 40 percent budget cuts, reports Genetic Engineering & Biotechnology News.
Institute Prof. Daron Acemoglu participated in a “global dialogue on artificial intelligence governance” at the United Nations, reports Steve Lohr for The New York Times. “The AI quest is currently focused on automating a lot of things, sidelining and displacing workers,” says Acemoglu.
In an opinion piece for the Financial Times, Prof. Evan Lieberman, director of the MIT Center for International Studies, spotlights how states, cities, corporations, and civil society are working to advance climate action. “Today, over 300 U.S. cities have made climate commitments, action plans, or are participating in co-operative initiatives,” Lieberman writes, “Large cities are connecting with global partners through organizations such as C40 Cities, a group of mayors representing some 700mn people worldwide.”